Drugs / Insulin Aspart 30/70
last change Jul 2012 re-read 2 minutes ago

Insulin Aspart 30/70

Developed for
type 2 diabetes mellitus

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01079364 Comparator Jan 2010 → Jul 2012 type 2 diabetes mellitus Sanofi Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Insulin Aspart 30/70 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01079364